Examiner: XIE, XIAOZHEN

Tech Center 1600 • Art Units: 1646 1674

This examiner grants 56% of resolved cases

Performance Statistics

56.4%

Allow Rate

-3.6% vs TC avg

707

Total Applications

+65.9%

Interview Lift

1311

Avg Prosecution Days

Based on 692 resolved cases, 2023–2026

3.5%

§101 Eligibility

20.3%

§102 Novelty

30.9%

§103 Obviousness

32.2%

§112 Clarity

App #	Title	Status	Assignee
17615959	ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS	Non-Final OA	Janssen Biotech, Inc.
18248280	TREATMENT OF FLARES IN LUPUS	Final Rejection	ASTRAZENECA AB

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.